Oral Mesalamine (Asacol) for Mildly to Moderately Active Ulcerative Colitis

Abstract

Colon-targeted oral mesalamine at 2.4 g/d is effective therapy for mildly to moderately active ulcerative colitis. It is well tolerated and should provide a viable therapeutic alternative to sulfasalazine.